Table 3 Baseline monocyte Telomere lengths according to demographic and clinical characteristics
From: Telomere attrition in heart failure: a flow-FISH longitudinal analysis of circulating monocytes
n = 101 | p | |
|---|---|---|
Age (years) | R = − 0.17 | 0.09 |
Sex | 0.44 | |
Male | 10.2 ± 2.9 | |
Female | 10.7 ± 4.2 | |
Etiology | 0.90§ | |
Ischemic heart disease | 10.4 ± 3.5 | |
Dilated cardiomyopathy | 10.3 ± 4.4 | |
Hypertensive cardiomyopathy | 10.5 ± 3.0 | |
Alcoholic cardiomyopathy | 9.5 ± 1.8 | |
Valvular disease | 9.1 ± 1.8 | |
Hypertrophic cardiomyopathy | 11.3 ± 3.3 | |
Other | 10.9 ± 2.5 | |
HF duration in months | Rho = − 0.13 | 0.20 |
LVEF | R = 0.14 | 0.18 |
NYHA functional class | 0.85§ | |
I | 10.4 ± 3.5 | |
II | 10.4 ± 3.6 | |
III | 10.0 ± 3.3 | |
Hypertension | 0.66 | |
Yes | 10.2 ± 3.5 | |
No | 10.5 ± 2.3 | |
Diabetes mellitus | 0.24 | |
Yes | 10.7 ± 3.4 | |
No | 9.9 ± 3.1 | |
Renal failurea | 0.31 | |
Yes | 10.0 ± 2.8 | |
No | 10.6 ± 3.6 | |
Anemiab | 0.23 | |
Yes | 10.8 ± 3.1 | |
No | 10.0 ± 3.3 | |
Atrial fibrillation/flutter | 0.01 | |
Yes | 9.3 ± 2.6 | |
No | 11 ± 3.5 | |
Obesity | 0.23 | |
Yes | 10.9 ± 3.6 | |
No | 10.1 ± 3.1 | |
Smoker | 0.48 | |
No | 10.4 ± 3.3 | |
Past | 10.3 ± 3.3 | |
Current | 8.6 ± 2.4 | |